October 15, 2020 – The REFLECT II randomized clinical trial evaluating the safety and efficacy of the Keystone Heart TriGuard 3 (TG3), a self-stabilizing cerebral embolic deflection filter used in...
Embolic Protection Devices
This channel includes news and new technology innovations for embolic protection systems to prevent emboli from flowing down stream (distally) in arteries due to interventional or TAVR procedures.
-
-
September 9, 2020 — The Society of Interventional Radiology (SIR) published new clinical practice guidelines that provide evidence-based...
-
July 20, 2018 — Boston Scientific Corp.
-
September 18, 2017 – Claret Medical announced publication of a new study in the...
The Keystone Heart TriGuard 3 (TG3) is a self-stabilizing cerebral embolic deflection filter used in patients undergoing transcatheter aortic valve replacement (TAVR). The device is designed to reduce TAVR complications of cerebral embolization and ischemic stroke.
News | Heart Valve Technology | October 15, 2020
October 15, 2020 – The REFLECT II randomized clinical trial evaluating the safety and efficacy of the Keystone Heart...
News | Vena Cava Filters | September 09, 2020
September 9, 2020 — The Society of Interventional Radiology (SIR) published new clinical practice guidelines that...
News | Embolic Protection Devices | August 06, 2019
August 6, 2019 — Cardiovascular Systems Inc. (CSI) has acquired the Wirion Embolic Protection System and related assets...
News | Embolic Protection Devices | July 19, 2019
July 19, 2019 — Medical device startup company Filterlex Medical recently completed a series A financing round, raising...
News | Embolic Protection Devices | August 03, 2018
August 3, 2018 — Boston Scientific Corp. announced it has recently closed its acquisition of Claret Medical Inc., a...
Claret's FDA-cleared Sentinel Cerebral Embolic Protection System for TAVR will expand Boston Scientific's structural heart portfolio. It collects emboli knocked loose that would otherwise lodge in the brain and potentially cause a stroke.
News | Embolic Protection Devices | July 20, 2018
July 20, 2018 — Boston Scientific Corp. today has signed an agreement to acquire Claret Medical Inc., which has...
The Emboliner Embolic Protection Catheter is designed to capture debris released from the valve and vessel walls during transcatheter aortic valve replacement (TAVR) procedures. It allows for the passage of other catheters during TAVR procedures.
News | Embolic Protection Devices | June 07, 2018
June 7, 2018 — The first clinical cases have been completed where the Emboliner Embolic Protection Catheter was used...
News | Embolic Protection Devices | May 08, 2018
May 8, 2018 — One-year results from the Sentinel Cerebral Protection System show it can reduce the incidence of stroke...
News | Embolic Protection Devices | April 20, 2018
April 20, 2018 — Emerging medical device company Emboline Inc. announced it has completed a Series B funding round...
News | Embolic Protection Devices | February 19, 2018
February 19, 2018 — Claret Medical announced that since U.S. Food and Drug Administration (FDA) clearance in June 2017...
The Boston Scientific FilterWire EZ embolic protection system.
News | Embolic Protection Devices | October 31, 2017
October 31, 2017 — The VAMPIRE 3 study evaluated if the selective use of distal filter protection might decrease the...
News | Embolic Protection Devices | October 23, 2017
October 23, 2017 — Claret Medical announced that it has closed on a Series C financing of $14.5 million led by...
News | Embolic Protection Devices | September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the Journal of the American College of...
News | Embolic Protection Devices | September 07, 2017
September 7, 2017 — Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System...
News | Embolic Protection Devices | August 23, 2017
August 23, 2017 — PinnacleHealth is the first hospital in Pennsylvania and one of the first 10 in the country to...
